We highlight the increased expression of immune-response-related genes FCGBP, BPIFB, F5, CST1, and CFB, and their correlation to epithelial-to-mesenchymal transition (EMT) under SMG, rendering them potential biomarkers of lung cancer progression. The gene discussed is FCGBP; the disease is lung carcinoma.